Clinical studies in patients with angina pectoris have suggested a beneficial effect following specific blockade of the beta-adrenergic sympathetic nerves that are responsible for autonomic stimulation of the myocardium (Dornhorst and Robinson, 1962; Apthorp, Chamberlain, and Hayward, 1964) . The present study is designed to assess the effect of a potent beta-adrenergic blocking agent, propranolol (inderal), on an objective measurement of exercise tolerance in patients with angina pectoris. A preliminary investigation (Hamer et al., 1964) suggested a favourable response in some subjects. In the present work we are particularly concerned to exclude a non-specific effect and to define the indications for cardiac sympathetic blockade.
SUBJECTS AND METHODS
A selected group of 14 patients was studied by means of a standardized exercise tolerance test, as in the preliminary investigation (Hamer et al., 1964) . Patients with any evidence of left ventricular failure were excluded, and each patient was limited by angina (or in two cases because of depression of the S-T segment in the electrocardiogram) in an initial exercise test and in tests performed after a placebo injection and after propranolol.
All the patients were having angina of effort of moderate severity during the course of their daily activities, and there had been no change in their condition in the last three months. Patients with angina at rest or on slight exertion were not studied. No patient with a casual diastolic blood pressure greater than 100 mm. Hg, or with valvar disease, was included in the investigation. Patients with left ventricular failure were excluded on the basis of a history of dyspncea on exertion, the presence of atrial or third heart sounds or delayed aortic valve closure, or radiological evidence of left ventricular enlargement or pulmonary venous congestion. Twelve Received August 25, 1965. *Present address: St. Bartholomew's Hospital, London, E.GC.1. patients presumably had coronary arteriosclerosis, but in 2 there was evidence of other types of coronary artery disease; one (S.P.) had polyarteritis nodosa in a quiescent phase, and in another (P.S.), a woman aged 40, there was positive serology, suggesting that the angina might be due to coronary ostial stenosis.
In all, 11 men and 3 women were studied, and their ages were between 40 and 69 years. Angina had been present for at least a year, and in some cases for much longer (Table I) ; most patients had been under observation in the clinic from the onset of symptoms. Major cardiac infarction had occurred in 4 subjects, in each case posteriorly, from 2 to 9 years previously. In 4 further subjects minor anterior ischxmic changes had occurred from 1 to 3 or more years earlier, but had subsequently regressed. No infarction had occurred in the remaining 6 patients, but 3 had persistent but minor (less than 1 mm.) depression of the S-T segments in the "left ventricular" leads (I, VL, V5, and V6).
The nature of the test was explained to the patients and their agreement was obtained before the study was begun. The patients were exercised in the sitting position on a Schonander-Elema bicycle ergometer (Holmgren and Mattsson, 1954) which maintains a constant load with wide variations in the rate of pedalling, and were warned that they must stop bicycling at the onset of angina. Exercise was begun at a work level of 100 kilopond-metres (kpm.) a minute (16 watts), and the load was increased at 6-minute intervals by 200 kpm./min. (33 watts). The electrocardiogram was monitored throughout the study, using a modified CR5 lead. Depression of the S-T segment was found in 9 patients, and in 2 there were multiple ventricular extrasystoles in the initial and placebo studies, but not after propranolol. Similar S-T segment changes were found in each of the three exercise periods (Fig. 1) . In 2 patients exercise was stopped on instruction in each part of the study before the onset of angina because of the appearance of major S-T segment displacement in the electrocardiogram. The angina produced during the test resembled the patient's natural attacks and passed off quickly when exercise was stopped. Any electrocardiographic changes were followed at intervals until the resting pattern returned. 14 
RESULTS
The total work performed by each subject in the initial test, after a placebo, and after propranolol, is shown in Table II . The patients fell into two groups: 5 subjects had severe angina as judged from an initial exercise tolerance of less than 600 kpm. (i.e. 6 min. at 100 kpm./min.), and the remaining 9 subjects had only moderate angina with an initial alfter exerc'ise I1.
FIG. 1.-The electrocardiogram before and after exercise in a representative subject. Similar changes in the S-T segment are evident immediately after exercise in the initial (control) test, following a placebo, and after propranolol. Angina was produced by the exercise in each test. The slower heart rate after propranolol is apparent both before and after exercise. exercise tolerance greater than 1500 kpm. (6 min. at 100 kpm./min. followed by 3 min. at 400 kpm./min.). The average changes in each group indicate a small placebo response and a greater increase in exercise tolerance after propranolol (Fig. 2) . The placebo response in individual subjects varied considerably, and in 5 patients exercise tolerance was reduced after the placebo (Fig. 3) . After propranolol exercise tolerance was greater than after the placebo, except in one subject who showed no change (Fig. 3) .
In the 5 patients with severe angina there was a significant difference (p <0-05) between the exercise tolerance after propranolol and the initial value. The 9 patients with moderate angina showed a highly significant increase beyond both the initial and the placebo response after propranolol (p < 0 005). The slowing of the heart on exercise after propranolol is clearly shown in this study (Table II and Fig. 3) ; there was an average fall in rate by 15% during exercise. Angina tended to occur at a similar heart rate in the initial test and after the placebo, but generally occurred at a lower heart rate after propranolol.
Correlation of the exercise response with the electrocardiographic findings was poor. The majority of patients with severe limitation of exercise tolerance had had major infarctions, and striking The change in total work in the graduated exercise test is expressed as a percentage of the initial exercise tolerance. There is a greater tendency to an increase in exercise tolerance after propranolol than after a placebo. The corresponding changes in heart rate are also shown.
increases in exercise tolerance were found in some patients in this group; many patients without infarction also showed considerable improvement. No untoward effects followed the exercise tests in these patients and there were no symptoms attributable to the drug. DISCUSSION The progressive increase in work load used in the present study was selected to provide a clear-cut limit to the exercise, and the total work performed during the test is a useful measure of exercise tolerance. The considerable variation in the placebo response may be related to the competing effects of the improvement produced by training on the bicycle and the effort required to exercise repeatedly to the limit of tolerance. Similar influences would be expected to follow the injection of propranolol. The "second wind" effect is unlikely to play a significant part as a 30-minute rest period was allowed between the tests (Wayne and Graybiel, 1934) . The tendency to a greater increase in exercise tolerance after the drug suggests that a real improvement has been produced in some cases. The bradycardia produced by propranolol makes it obvious to those conducting the test that an effective drug has been given so that a "doubleblind" study cannot be carried out. The absence of any change in heart rate following the placebo indicates that there are no significant spontaneous variations in adrenergic activity.
Abnormalities ofventricular contraction have been reported in ischlmic heart disease (Messer et al., 1963) , and there is evidence that the cardiac output is reduced on exercise in these patients (Foster and Reeves, 1964) . Beta-adrenergic blockade has been shown to reduce myocardial contractility (Harrison et al., 1964) , and might be expected to accentuate these changes. Patients with any evidence of left ventricular failure were, therefore, excluded from the present study. In this selected group of patients the improvement in exercise tolerance could not be correlated with the evidence of previous infarction or other electrocardiographic changes. Considerable improvement was noted both in patients with healed major infarction and among those with normal electrocardiograms.
Several studies have suggested that the cardiac output is relatively unaffected by beta-adrenergic blockade in normal subjects in the upright position (Bishop and Segel, 1963; Chamberlain and Howard, 1964) . However, more recent work has indicated a fall in output after propranolol (Robinson et al., 1965) , and we have shown a similar reduction in patients with ischamic heart disease, both at rest and on exercise (Hamer and Sowton, 1965) . A beneficial effect in angina is therefore associated with a reduction in tissue blood flow, at least in some parts ofthe peripheral vascular bed. These changes are probably secondary to interference with myocardial contractility. More efficient utilization of the available supply of oxygen to the heart as myocardial contractility is reduced (Apthorp et al., 1964) is probably the fundamental factor in the improvement in exercise tolerance.
It is clear from the present study that the heart rate is not a critical factor in the production of angina in ischsEmic heart disease, as angina generally begins at a slower rate after propranolol. It has been suggested that the relative bradycardia produced by propranolol may allow longer diastolic pauses and consequently greater coronary flow. However, there is evidence that the prolongation of systole due to reduced myocardial contractility prevents any increase in diastolic time (Apthorp et al., 1964 ; J. Hamer, T. Grandjean, L. Melendez, and E. Sowton, 1965, unpublished work (Gregg, 1964) .
Clinical trials of prolonged oral treatment with beta-adrenergic blocking agents in angina pectoris have been restricted by side-effects and by variations in absorption of the drug (Alleyne et al., 1963; Srivastava, Dewar, and Newell, 1964; Keelan, 1965; Gillam and Prichard, 1965) Five patients with severe angina showed some improvement in exercise tolerance after propranolol. Nine patients with moderate angina showed a significant increaseq in exercise tolerance beyond that found after the inert injection.
These findings suggest that beta-adrenergic blockade improves the exercise tolerance of some patients with angina pectoris. The possible deleterious effects of the associated reduction in myocardial contractility and in peripheral blood flow must be borne in mind in considering the therapeutic use of propranolol in patients with isch.emic heart disease. 
